Skip to main content
Funded Studies

Benny Bang-Andersen, MSc/PhD

Senior Director at H. Lundbeck A/S

Location: Copenhagen Denmark

Dr. Benny Bang-Andersen obtained an MSc in chemistry from University College London and an MSc in pharmacy and a PhD in medicinal chemistry from the Royal Danish School of Pharmacy, which today is part of the Faculty of Health and Medical Sciences, University of Copenhagen. Dr. Bang-Andersen has worked in drug discovery for nearly 30 years, and he has extensive leadership experience as drug discovery project leader, line manager in research and senior scientist in R&D. Dr. Bang-Andersen has led research toward the nomination of several clinical drug candidates, including the Medicinal Chemistry Team discovering the blockbuster antidepressant vortioxetine (trade names Brintellix/Trintellix). Dr. Bang-Andersen’s current focus is on preclinical molecular imaging, including the discovery and development of novel molecular imaging ligands and technologies to support translation of drug projects from animals to humans.

Associated Grants

  • Discovery of Novel Radiolabeled Tracers for Imaging Microglia Associated with Neuroinflammation in Parkinson’s disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.